Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where S. Sinclair is active.

Publication


Featured researches published by S. Sinclair.


Heart Lung and Circulation | 2017

Pacemaker Use in New Zealand – Data From the New Zealand Implanted Cardiac Device Registry (ANZACS-QI 15)

P. Larsen; Andrew Kerr; Margaret Hood; S. Harding; Darren Hooks; D. Heaven; Nigel Lever; S. Sinclair; Dean Boddington; E.W. Tang; J. Swampillai; Martin K. Stiles

BACKGROUND The New Zealand Cardiac Implanted Device Registry (Device) has recently been developed under the auspices of the New Zealand Branch of the Cardiac Society of Australia and New Zealand. This study describes the initial Device registry cohort of patients receiving a new pacemaker, their indications for pacing and their perioperative complications. METHODS The Device Registry was used to audit patients receiving a first pacemaker between 1st January 2014 and 1st June 2015. RESULTS We examined 1611 patients undergoing first pacemaker implantation. Patients were predominantly male (59%), and had a median age of 70 years. The most common symptom for pacemaker implantation was syncope (39%), followed by dizziness (30%) and dyspnoea (12%). The most common aetiology for a pacemaker was a conduction tissue disorder (35%), followed by sinus node dysfunction (22%). Atrioventricular (AV) block was the most common ECG abnormality, present in 44%. Dual chamber pacemakers were most common (62%), followed by single chamber ventricular pacemakers (34%), and cardiac resynchronisation therapy - pacemakers (CRT-P) (2%). Complications within 24hours of the implant procedure were reported in 64 patients (3.9%), none of which were fatal. The most common complication was the need for reoperation to manipulate a lead, occurring in 23 patients (1.4%). CONCLUSION This is the first description of data entered into the Device registry. Patients receiving a pacemaker were younger than in European registries, and there was a low use of CRT-P devices compared to international rates. Complications rates were low and compare favourably to available international data.


Heart Lung and Circulation | 2013

Emergency Cardiac Resynchronisation in a 4 kg Infant Post Surgical Closure of Ventricular Septal Defect

Michael Yeong; Elizabeth Rumball; S. Sinclair; Jonathan R. Skinner

Cardiac resynchronisation therapy (CRT) is an established treatment for adult patients with cardiac failure due to mechanical and electrical dyssynchrony. Data on CRT in infants are scarce. We report the remarkable success of emergent CRT by epicardial pacing of the left ventricular apex in a 4kg infant with left ventricular failure due to LV dyssynchrony from left bundle branch block.


Heart Lung and Circulation | 2013

Clinical SpotlightEmergency Cardiac Resynchronisation in a 4 kg Infant Post Surgical Closure of Ventricular Septal Defect

Michael Yeong; Elizabeth Rumball; S. Sinclair; Jonathan R. Skinner

Cardiac resynchronisation therapy (CRT) is an established treatment for adult patients with cardiac failure due to mechanical and electrical dyssynchrony. Data on CRT in infants are scarce. We report the remarkable success of emergent CRT by epicardial pacing of the left ventricular apex in a 4kg infant with left ventricular failure due to LV dyssynchrony from left bundle branch block.


Heart Lung and Circulation | 2018

Pacemaker Implantation Practice and Early Complications in New Zealand: A 3 Year Analysis from the All New Zealand Acute Coronary Syndrome- Quality Improvement Device Registry (ANZACS-QI DEVICE)

Fang Shawn Foo; J. Voss; Martin K. Stiles; Scott A. Harding; S. Sinclair; Dean Boddington; Andrew Kerr


Heart Lung and Circulation | 2018

Implantable Cardioverter Defibrillator (ICD) Use in New Zealand: A 3 Year Analysis from the All New Zealand Acute Coronary Syndrome- Quality Improvement Device Registry (ANZACS-QI DEVICE)

Fang Shawn Foo; J. Voss; Martin K. Stiles; Scott A. Harding; S. Sinclair; Dean Boddington; Andrew Kerr


Heart Lung and Circulation | 2013

Implantable Cardioverter Defibrillator Use Prior to Cardiac Transplantation

J. Voss; A. Martin; S. Sinclair; Peter Ruygrok; N. Lever


Heart Lung and Circulation | 2012

The Green Lane and Auckland City Hospital Cardiac Resynchronisation Therapy Experience

A. Martin; S. Sinclair; Margaret Hood; N. Lever; James T. Stewart


Heart Lung and Circulation | 2012

Medtronic Carelink Remote Monitoring the Auckland City Hospital (ACH) Setup Experience

C. Pearson; S. Sinclair; F. Riddell


Heart Lung and Circulation | 2012

A Decade of Cardiac Resynchronisation Therapy: The Green Lane and Auckland City Hospital Experience

Andrew Martin; S. Sinclair; Margaret Hood; Nigel Lever; James T. Stewart


Heart Lung and Circulation | 2012

Implantable Cardioverter Defibrillator (ICE) Use in Hypertrophic Cardiomyopathy—Ten-Year Auckland Experience

J. White; S. Sinclair; F. Riddell; Margaret Hood; Nigel Lever; W.M. Smith

Collaboration


Dive into the S. Sinclair's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

F. Riddell

Auckland City Hospital

View shared research outputs
Top Co-Authors

Avatar

Nigel Lever

Auckland City Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

W.M. Smith

Auckland City Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D. Heaven

Auckland City Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J. Voss

Auckland City Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge